Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 455

1.

Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.

Deane R, Zlokovic BV.

Curr Alzheimer Res. 2007 Apr;4(2):191-7. Review.

PMID:
17430246
2.

Evidence for altered LRP/RAGE expression in Alzheimer lesion pathogenesis.

Jeynes B, Provias J.

Curr Alzheimer Res. 2008 Oct;5(5):432-7.

PMID:
18855584
3.

Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.

Lue LF, Yan SD, Stern DM, Walker DG.

Curr Drug Targets CNS Neurol Disord. 2005 Jun;4(3):249-66. Review.

PMID:
15975028
4.

Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease.

Donahue JE, Johanson CE.

J Neuropathol Exp Neurol. 2008 Apr;67(4):261-70. doi: 10.1097/NEN.0b013e31816a0dc8. Review. Erratum in: J Neuropathol Exp Neurol. 2008 Jun;67(6):634.

PMID:
18379441
5.

Functional role of lipoprotein receptors in Alzheimer's disease.

Jaeger S, Pietrzik CU.

Curr Alzheimer Res. 2008 Feb;5(1):15-25. Review.

PMID:
18288927
6.

Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests.

Bates KA, Verdile G, Li QX, Ames D, Hudson P, Masters CL, Martins RN.

Mol Psychiatry. 2009 May;14(5):469-86. doi: 10.1038/mp.2008.96. Epub 2008 Sep 16. Review. Erratum in: Mol Psychiatry. 2009 Dec;14(12):1144.

PMID:
18794889
7.

RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease.

Donahue JE, Flaherty SL, Johanson CE, Duncan JA 3rd, Silverberg GD, Miller MC, Tavares R, Yang W, Wu Q, Sabo E, Hovanesian V, Stopa EG.

Acta Neuropathol. 2006 Oct;112(4):405-15. Epub 2006 Jul 25.

PMID:
16865397
8.

Crosstalk between calcium, amyloid beta and the receptor for advanced glycation endproducts in Alzheimer's disease.

Leclerc E, Sturchler E, Vetter SW, Heizmann CW.

Rev Neurosci. 2009;20(2):95-110. Review.

PMID:
19774788
9.

RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain.

Deane R, Du Yan S, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, Welch D, Manness L, Lin C, Yu J, Zhu H, Ghiso J, Frangione B, Stern A, Schmidt AM, Armstrong DL, Arnold B, Liliensiek B, Nawroth P, Hofman F, Kindy M, Stern D, Zlokovic B.

Nat Med. 2003 Jul;9(7):907-13.

PMID:
12808450
10.

Clearing amyloid through the blood-brain barrier.

Zlokovic BV.

J Neurochem. 2004 May;89(4):807-11. Review.

11.

Amyloid beta interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier.

Li M, Shang DS, Zhao WD, Tian L, Li B, Fang WG, Zhu L, Man SM, Chen YH.

J Immunol. 2009 May 1;182(9):5778-88. doi: 10.4049/jimmunol.0803013.

12.

Neurovascular mechanisms of Alzheimer's neurodegeneration.

Zlokovic BV.

Trends Neurosci. 2005 Apr;28(4):202-8. Review.

PMID:
15808355
13.

Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.

Bell RD, Zlokovic BV.

Acta Neuropathol. 2009 Jul;118(1):103-13. doi: 10.1007/s00401-009-0522-3. Epub 2009 Mar 25. Review.

14.

Clearance of Alzheimer's Abeta peptide: the many roads to perdition.

Tanzi RE, Moir RD, Wagner SL.

Neuron. 2004 Sep 2;43(5):605-8. Review.

15.

Neurovascular pathways and Alzheimer amyloid beta-peptide.

Zlokovic BV, Deane R, Sallstrom J, Chow N, Miano JM.

Brain Pathol. 2005 Jan;15(1):78-83. Review.

PMID:
15779240
16.
17.

Dietary fats, cerebrovasculature integrity and Alzheimer's disease risk.

Takechi R, Galloway S, Pallebage-Gamarallage MM, Lam V, Mamo JC.

Prog Lipid Res. 2010 Apr;49(2):159-70. doi: 10.1016/j.plipres.2009.10.004. Epub 2009 Nov 5. Review.

PMID:
19896503
18.

Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.

Lue LF, Walker DG, Brachova L, Beach TG, Rogers J, Schmidt AM, Stern DM, Yan SD.

Exp Neurol. 2001 Sep;171(1):29-45.

PMID:
11520119
19.

IgG-assisted age-dependent clearance of Alzheimer's amyloid beta peptide by the blood-brain barrier neonatal Fc receptor.

Deane R, Sagare A, Hamm K, Parisi M, LaRue B, Guo H, Wu Z, Holtzman DM, Zlokovic BV.

J Neurosci. 2005 Dec 14;25(50):11495-503.

20.

[Blood-brain barrier and Alzheimer's disease].

Kuwahara H, Nishida Y, Yokota T.

Brain Nerve. 2013 Feb;65(2):145-51. Review. Japanese.

PMID:
23399672

Supplemental Content

Support Center